According to the company, volunteers who became infected up to a week after taking the antibody were 51% less likely to develop symptoms.
कंपनी ने कहा कि दवा लेने के एक हफ्ते बाद तक संक्रमित होने वाले स्वयंसेवकों में लक्षण विकसित होने की संभावना 51% कम थी।